Verified email-pattern data for Renatus is currently limited. You can still use the company insights and contact sections below.
Renatus is an early-stage biotech company dedicated to developing innovative therapies that directly target and reverse cellular cholesterol accumulation—a key hallmark of various age-related and metabolic diseases. The company's diverse pipeline encompasses a wide range of therapeutic areas, including chronic kidney disease, atherosclerosis, Alzheimer's disease, Niemann-Pick Type C disease, metabolic-associated steatohepatitis (MASH), and cancer.
At the core of Renatus’s approach is the selective targeting of excess cholesterol, particularly within lysosomes, without disrupting cholesterol essential for normal cellular processes. This innovation addresses a critical challenge in cholesterol-targeting therapies: while cholesterol is vital for numerous physiological functions and is ubiquitous in cells, its abnormal accumulation in specific compartments, such as lysosomes, drives the progression of many diseases. Traditional cholesterol-targeting strategies often interfere with normal cholesterol functions, leading to significant adverse effects.
Importantly, the removal of lysosomal cholesterol induces effects beyond simply lowering cholesterol levels. It reprograms key cellular pathways, including mitochondrial homeostasis, lipid synthesis and metabolism, inflammation regulation, and cell survival mechanisms.
By addressing abnormal cholesterol accumulation, Renatus’s technology has the potential to improve cellular health, restore lipid metabolism, and transform the treatment landscape for diseases such as atherosclerosis, chronic kidney disease, Alzheimer's disease, and more.
Company Details
- Founded
- -
- Address
- Daejeon, Yuseong-Gu 34013, Kr
- Industry
- Pharmaceutical Manufacturing
- Website
- http://renatustx.com
- HQ
- Daejeon, Yuseong-gu
Renatus Questions
Renatus's website is http://renatustx.com
Renatus's LinkedIn profile is https://kr.linkedin.com/company/renatustx
Renatus's industry is
Pharmaceutical Manufacturing
Renatus's top competitors are
Chembind Glycoscience,
Dongkook Pharmaceutical Co Ltd,
European Biopharma Therapeutics,
Glycoscience Inc,
Amtixbio,
Glycomira Therapeutics, Inc.,
Bioneex,
Carbohyde,
The Movement Laboratory Pte Ltd,
Aventine.
Renatus's categories are Pharmaceutical Manufacturing
Renatus's founding year is 2021
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.